Pay in 4 interest-free payments of $6.61 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
The proportion of participants achieving 20% or greater weight loss was 36% at the 10mg dose and 40% at the 15mg dose, results approaching what was previously achievable only with bariatric surgery
Our medical team will assess your health and determine the most appropriate treatment plan
AOD-9604 was originally developed as a potential anti-obesity drug due to its ability to promote fat loss without significantly impacting muscle growth or insulin levels
Improved insulin sensitivity means your cells can more effectively take up glucose from the bloodstream, reducing the metabolic stress that contributes to type 2 diabetes and metabolic syndrome
These limitations dont invalidate the positive safety findings but do suggest that comprehensive medical supervision remains appropriate for anyone using AOD-9604, particularly for off-label applications or extended treatment periods
Signal sensitivity pulsed dosing is the conservative way to avoid blunting the response over time
